242 related articles for article (PubMed ID: 22049082)
1. FHL2 protein is a novel co-repressor of nuclear receptor Nur77.
Kurakula K; van der Wal E; Geerts D; van Tiel CM; de Vries CJ
J Biol Chem; 2011 Dec; 286(52):44336-43. PubMed ID: 22049082
[TBL] [Abstract][Full Text] [Related]
2. The LIM domain protein FHL2 interacts with the NR5A family of nuclear receptors and CREB to activate the inhibin-α subunit gene in ovarian granulosa cells.
Matulis CK; Mayo KE
Mol Endocrinol; 2012 Aug; 26(8):1278-90. PubMed ID: 22734036
[TBL] [Abstract][Full Text] [Related]
3. KLF8 promotes tumorigenesis, invasion and metastasis of colorectal cancer cells by transcriptional activation of FHL2.
Yan Q; Zhang W; Wu Y; Wu M; Zhang M; Shi X; Zhao J; Nan Q; Chen Y; Wang L; Cheng T; Li J; Bai Y; Liu S; Wang J
Oncotarget; 2015 Sep; 6(28):25402-17. PubMed ID: 26320172
[TBL] [Abstract][Full Text] [Related]
4. LIM-only protein FHL2 is a positive regulator of liver X receptors in smooth muscle cells involved in lipid homeostasis.
Kurakula K; Sommer D; Sokolovic M; Moerland PD; Scheij S; van Loenen PB; Koenis DS; Zelcer N; van Tiel CM; de Vries CJ
Mol Cell Biol; 2015 Jan; 35(1):52-62. PubMed ID: 25332231
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of the tumor suppressor FHL2 by p53 in human kidney and liver cells.
Xu J; Zhou J; Li MS; Ng CF; Ng YK; Lai PB; Tsui SK
PLoS One; 2014; 9(8):e99359. PubMed ID: 25121502
[TBL] [Abstract][Full Text] [Related]
6. Four and a half LIM domains 2 contributes to the development of human tongue squamous cell carcinoma.
Wang Q; Wang X; Tian X; Tang R; Xu X
J Mol Histol; 2016 Apr; 47(2):105-16. PubMed ID: 26759260
[TBL] [Abstract][Full Text] [Related]
7. FHL2 interacts with iASPP and impacts the biological functions of leukemia cells.
Lu W; Yu T; Liu S; Li S; Li S; Liu J; Xu Y; Xing H; Tian Z; Tang K; Rao Q; Wang J; Wang M
Oncotarget; 2017 Jun; 8(25):40885-40895. PubMed ID: 28402264
[TBL] [Abstract][Full Text] [Related]
8. The LIM-only protein FHL2 reduces vascular lesion formation involving inhibition of proliferation and migration of smooth muscle cells.
Kurakula K; Vos M; Otermin Rubio I; Marinković G; Buettner R; Heukamp LC; Stap J; de Waard V; van Tiel CM; de Vries CJ
PLoS One; 2014; 9(4):e94931. PubMed ID: 24736599
[TBL] [Abstract][Full Text] [Related]
9. LIM-only protein FHL2 attenuates inflammation in vascular smooth muscle cells through inhibition of the NFκB pathway.
van de Pol V; Vos M; DeRuiter MC; Goumans MJ; de Vries CJM; Kurakula K
Vascul Pharmacol; 2020; 125-126():106634. PubMed ID: 31866461
[TBL] [Abstract][Full Text] [Related]
10. The four and a half LIM domains 2 (FHL2) regulates ovarian granulosa cell tumor progression via controlling AKT1 transcription.
Hua G; He C; Lv X; Fan L; Wang C; Remmenga SW; Rodabaugh KJ; Yang L; Lele SM; Yang P; Karpf AR; Davis JS; Wang C
Cell Death Dis; 2016 Jul; 7(7):e2297. PubMed ID: 27415427
[TBL] [Abstract][Full Text] [Related]
11. Dual function of Pin1 in NR4A nuclear receptor activation: enhanced activity of NR4As and increased Nur77 protein stability.
van Tiel CM; Kurakula K; Koenis DS; van der Wal E; de Vries CJ
Biochim Biophys Acta; 2012 Oct; 1823(10):1894-904. PubMed ID: 22789442
[TBL] [Abstract][Full Text] [Related]
12. FHL2 binds calcineurin and represses pathological cardiac growth.
Hojayev B; Rothermel BA; Gillette TG; Hill JA
Mol Cell Biol; 2012 Oct; 32(19):4025-34. PubMed ID: 22851699
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of four-and-a-half LIM domain protein-2 increases survival, migratory capacity, and paracrine function of human early outgrowth cells through activation of the sphingosine kinase-1 pathway: implications for endothelial regeneration.
Ebrahimian T; Arfa O; Simeone S; Lemarié CA; Lehoux S; Wassmann S
Circ Res; 2014 Jan; 114(1):114-23. PubMed ID: 24084691
[TBL] [Abstract][Full Text] [Related]
14. Expression, location and biological effects of four and a half LIM domain protein 2 (FHL2) on granulosa cells in ovine.
Zhang L; Li R; Chen L; Xing Z; Song Y; Nie X; Wang L; Han H; Liu A; Ma X; Ma RZ; Tian S
Reprod Domest Anim; 2020 Jun; 55(6):737-746. PubMed ID: 32181932
[TBL] [Abstract][Full Text] [Related]
15. The atypical orphan nuclear receptor DAX-1 interacts with orphan nuclear receptor Nur77 and represses its transactivation.
Song KH; Park YY; Park KC; Hong CY; Park JH; Shong M; Lee K; Choi HS
Mol Endocrinol; 2004 Aug; 18(8):1929-40. PubMed ID: 15155786
[TBL] [Abstract][Full Text] [Related]
16. The FHL2 regulation in the transcriptional circuitry of human cancers.
Cao CY; Mok SW; Cheng VW; Tsui SK
Gene; 2015 Nov; 572(1):1-7. PubMed ID: 26211626
[TBL] [Abstract][Full Text] [Related]
17. Autophagy Induced FHL2 Upregulation Promotes IL-6 Production by Activating the NF-κB Pathway in Mouse Aortic Endothelial Cells after Exposure to PM2.5.
Xia WR; Fu W; Wang Q; Zhu X; Xing WW; Wang M; Xu DQ; Xu DG
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28714941
[TBL] [Abstract][Full Text] [Related]
18. Proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein 2.
Nair SS; Guo Z; Mueller JM; Koochekpour S; Qiu Y; Tekmal RR; Schüle R; Kung HJ; Kumar R; Vadlamudi RK
Mol Endocrinol; 2007 Mar; 21(3):613-24. PubMed ID: 17192406
[TBL] [Abstract][Full Text] [Related]
19. NR4A receptors up-regulate the antiproteinase alpha-2 macroglobulin (A2M) and modulate MMP-2 and MMP-9 in vascular smooth muscle cells.
Rodríguez-Calvo R; Ferrán B; Alonso J; Martí-Pàmies I; Aguiló S; Calvayrac O; Rodríguez C; Martínez-González J
Thromb Haemost; 2015 Jun; 113(6):1323-34. PubMed ID: 25809189
[TBL] [Abstract][Full Text] [Related]
20. Deletion of FHL2 gene impaired ischemia-induced blood flow recovery by modulating circulating proangiogenic cells.
Huang PH; Chen CY; Lin CP; Wang CH; Tsai HY; Lo WY; Leu HB; Chen JW; Lin SJ; Chu PH
Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):709-17. PubMed ID: 23413425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
